2026/08/06
BEIJING, China, August X, 2026 — SINOVAC announced that its Serum-Free Rabies Vaccine for Human Use has received a Drug Registration Certificate from China's National Medical Products Administrati
BEIJING -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has extended the dead
2026/07/15
BEIJING, June 24, 2026 — SINOVAC and GENNVAX, Egyptian local partner, signed an agreement for the localized production of influenza and Sabin-strain inactivated poliovirus (sIPV) vaccines during the 5
2026/06/24
Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading biopharmaceutical enterprise from China, recently hosted more than 100 public health and
2026/06/18
The content is intended for use by media professionals
These images may be downloaded for non-commercial use and for purposes such as news reporting or research. Images may not be modified and must display the following copyright language: Copyright © SINOVAC Biotech Ltd. All rights reserved.
Learn more about SINOVAC copyright and trademark policies.
Media Contacts: pr@sinovac.com
EN
